Cutler Group LP Chembio Diagnostics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Oct 26, 2021	BUY	$2.06 - $5.34 $31,518 - $81,702	15,300 Added 1912.5%	16,100 $50,000
Q1 2021 Apr 26, 2021	BUY	$3.4 - $7.97 $2,040 - $4,782	600 Added 300.0%	800 $0
Q4 2020 Jan 21, 2021	SELL	$4.11 - $7.51 $1,233 - $2,253	-300 Reduced 60.0%	200 $0
Q3 2020 Oct 27, 2020	SELL	$3.28 - $5.93 $23,288 - $42,103	-7,100 Reduced 93.42%	500 $1,000
Q2 2020 Jul 22, 2020	BUY	$3.18 - $15.54 $24,168 - $118,104	7,600 New	7,600 $37,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.